References
- B. Angelin, A. Arvidsson, R. Dahlqvist, A. Hedman and K. Schenk-Gustafsson. Quinidine reduces biliary clearance of digoxin in man. Eur. J. Clin. Inves., 17, 262-265 (1987) https://doi.org/10.1111/j.1365-2362.1987.tb01246.x
- M. Verschraagen, C.H.W. Koks, J.H.M. Schellens and J.H. Beijnen. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil. Pharmacol. Res., 40, 301-306 (1999) https://doi.org/10.1006/phrs.1999.0535
- K. Westphal, A. Weinbrenner, T. Giessmann, M. Stuhr, G. Franke, M. Zschiesche, R. Oertel, B. Terhaag, H.K. Kroemer and W. Siegmund. Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement of intestinal P-glycoprotein. Clin. Pharmacol. Ther., 68, 6-12 (2000) https://doi.org/10.1067/mcp.2000.107579
- M.J.M. Hitchcock, H.S. Jaffe, J.C. Martin and RJ. Stagg. Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral. Chem. Chemother., 7, 115-127 (1996) https://doi.org/10.1177/095632029600700301
- B.C. Burckhardt and G. Burckhardt. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev. Physiol. Biochem. Pharmacol., 146, 95-158 (2003) https://doi.org/10.1007/s10254-002-0003-8
- M. Takeda, E. Babu, S. Narikawa and H. Endou. Interaction of human organic anion transporters with various cephalosporin antibiotics. Eur. J. Pharmacol., 438, 137-142 (2002) https://doi.org/10.1016/S0014-2999(02)01306-7
- H. Hasannejad, M. Takeda, K. Taki, H.J. Shin, E. Babu, P. Jutabha, S. Khamdang, M. Aleboyeh, M.L. Onozato, A. Tojo, A. Enomoto, N. Anzai, S. Narikawa, X.L. Huang, T. Niwa and H. Endo. Interactions of human organic anion transporters with diuretics. J. Pharmacol. Exp. Ther., 308, 1021-1029 (2004) https://doi.org/10.1124/jpet.103.059139
- S. Khamdang, M. Takeda, R. Noshiro, S. Narikawa, A. Enomoto, A. Anzei, P. Piyachaturawat and H. Endou. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther., 303, 534-539 (2002) https://doi.org/10.1124/jpet.102.037580
- M. Takeda, S. Khamdang, S. Narikawa, H. Kimura, Y. Kobayashi, T. Yamamoto, S.H. Cha, T. Sekine and H. Endou. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J. Pharmacol. Exp. Ther., 300, 918-924 (2002) https://doi.org/10.1124/jpet.300.3.918
- H. Motohashi, Y. Sakurai, H. Saito, S. Masuda, Y. Urakami, M. Goto, A. Fukatsu, O. Ogawa and K. Inui. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J. Am. Soc. Nephrol., 13, 866-874 (2002)
- A.G. Aslamkhan, Y.H. Han, X.P. Yang, R.K. Zalups and J.B. Pritchard. Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells. Mol. Pharmacol., 63, 590-596 (2003) https://doi.org/10.1124/mol.63.3.590
- J. Crookes, I.H. Stevenson, A.M.M. Shepherd and D.C. Muir. The clinical significance and importance of drug interactions. In Drug Interactions, Grahame-Smith (ed). Macmillan: London, 3-13 (1977)
- K.J. Starr and J.C. Petrie. Drug interactions in patients on long-term oral anticoagulant and antihypertensive adrenergic neuron-blocking drugs. BMJ., 4, 133-135 (1972) https://doi.org/10.1136/bmj.4.5833.133
- H. Ueo, H. Motohashi, T. Katsura and K. Inui. Human organic anion transporter hOAT3 is a potent transporter of cephalo- sporin antibiotics, in comparison with hOAT1. Biochem. Pharmacol., 70, 1104-13 (2005) https://doi.org/10.1016/j.bcp.2005.06.024
- S.H. Cha, T. Sekine, J-I. Fukushima, Y. Kanai, Y. Kobayashi, T. Goya and H. Endou. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol. Pharmacol., 59, 1277-1286 (2001) https://doi.org/10.1124/mol.59.5.1277